It's an exciting time to be in cell therapy manufacturing and commercialization, particularly in the oncology space. This year alone, we've seen the US approval of three cell therapy products: Iovance ...
CellFiber Co., Ltd., a Tokyo-based biotechnology company developing 3D cell culture and bioprocessing technology for ...
Capitalize on GMP-certified CDMOs, regulatory fast tracks and key bio-clusters; prioritize contract manufacturing, commercial scale-up and gene therapy capabilities.Dublin, Oct. 01, 2026 (GLOBE ...
Cellares co-founders Omar Kurdi (left) and Fabian Gerlinghaus pose with the company's Cell Shuttle manufacturing platform. Kite Pharma will conduct a proof-of-concept evaluation of the platform, the ...
At the 2024 annual meeting of the International Society for Cell & Gene Therapy (ISCT) in Vancouver, Canada, Hélio Tomás, PhD, senior research associate at the Instituto de Biologia Experimental e ...
Cellex Cell Professionals has surpassed 10,000 autologous manufacturing batches for advanced therapy medicinal products ...
FLORHAM PARK, N.J. & SINGAPORE--(BUSINESS WIRE)--Celularity Inc. (Nasdaq: CELU) (“Celularity”), a longevity-focused regenerative and cellular medicine company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results